71250	O	O
CT	O	O
CHEST	O	O
wo	O	O
CT	O	O
05/09/2007	O	O
ES	O	O
>	O	O
<	O	O
REPOUnenhanced	O	O
chest	O	O
CT	O	O
compared	O	O
to	O	O
prior	O	O
examination	O	O
dated	O	O
10-23-06	O	O
,	O	O
shows	O	O
no	O	O
interval	O	O
change	O	O
.	O	O
PO	O	O
left	O	O
pneumonectomy	O	O
.	O	O
Small	O	O
irregular	O	O
nodules	O	O
in	O	O
the	O	O
right	O	O
lung	O	O
are	O	O
unchanged	O	O
from	O	O
previous	O	O
study	O	O
of	O	O
9-27-04	O	O
,	O	O
and	O	O
,	O	O
therefore	O	O
,	O	O
should	O	O
be	O	O
benign	O	O
.	O	O
No	O	O
new	O	O
pulmonary	O	O
nodules	O	O
.	O	O
No	O	O
lymphadenopathy	O	O
.	O	O
Mild	3_Yellow_Days	O
changes	O	O
of	O	O
emphysema	3_Yellow_Days	O
in	O	O
the	O	O
right	3_Yellow_Days	O
lung	3_Yellow_Days	O
.	O	O
Slight	O	O
fibrosis	O	O
right	O	O
base	O	O
.	O	O
Vascular	O	O
including	O	O
coronary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
calcifications	3_Yellow_Days	3_Yellow_Days
.	O	O
37817795	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
Chest	O	O
,	O	O
09/08/2008	O	O
.	O	O
Clinical	O	O
History	O	O
:	O	O
Fibrous	O	O
histiocytoma	O	O
.	O	O
Evaluate	O	O
for	O	O
metastases	O	O
.	O	O
Findings	O	O
:	O	O
As	O	O
noted	O	O
,	O	O
there	O	O
are	O	O
posttreatment	O	O
changes	O	O
in	O	O
both	O	3_Yellow_Days
lungs	O	3_Yellow_Days
and	O	3_Yellow_Days
pleural	O	3_Yellow_Days
and	O	O
parenchymal	O	O
features	O	O
with	O	O
the	O	O
most	O	O
noted	O	O
in	O	O
the	O	O
left	O	O
lateral	O	O
posterior	O	O
chest	O	O
wall	O	O
.	O	O
This	O	O
area	O	O
does	O	O
have	O	O
some	O	O
pleural	O	O
and	O	O
reactive	O	O
changes	O	O
.	O	O
Many	O	O
sites	O	O
have	O	O
been	O	O
present	O	O
for	O	O
some	O	O
time	O	O
;	O	O
however	O	O
,	O	O
there	O	O
is	O	O
one	3_Yellow_Days	O
focal	3_Yellow_Days	O
area	3_Yellow_Days	O
that	3_Yellow_Days	O
is	3_Yellow_Days	O
a	3_Yellow_Days	O
little	3_Yellow_Days	O
bit	3_Yellow_Days	O
more	3_Yellow_Days	O
prominent	3_Yellow_Days	O
than	3_Yellow_Days	O
the	3_Yellow_Days	O
other	3_Yellow_Days	O
.	O	O
This	3_Yellow_Days	O
is	3_Yellow_Days	O
indeterminate	3_Yellow_Days	O
at	O	O
this	O	O
time	O	O
and	O	O
suggest	O	O
continued	3_Yellow_Days	O
evaluation	3_Yellow_Days	O
on	O	O
routine	O	O
fashion	O	O
or	O	O
if	O	O
any	O	O
clinical	O	O
findings	O	O
at	O	O
this	O	O
site	O	O
,	O	O
followup	3_Yellow_Days	O
intervention	3_Yellow_Days	O
with	3_Yellow_Days	O
MRI	3_Yellow_Days	O
may	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
helpful	3_Yellow_Days	3_Yellow_Days
.	O	O
However	O	O
,	O	O
these	O	O
findings	O	O
on	O	O
the	O	O
CT	O	O
are	O	O
indeterminate	O	O
.	O	O
No	O	O
evidence	O	O
of	O	O
new	O	O
parenchymal	O	O
pulmonary	O	O
nodules	O	O
,	O	O
and	O	O
the	O	O
intrathoracic	O	O
opacities	O	O
are	O	O
similar	O	O
to	O	O
prior	O	O
studies	O	O
of	O	O
01/07/2008	O	O
.	O	O
IMPRESSION	O	O
:	O	O
1	O	O
.	O	O
Bilateral	O	3_Yellow_Days
pleural	O	3_Yellow_Days
and	O	O
parenchymal	O	O
posttreatment	O	O
changes	O	O
with	O	O
the	O	O
most	O	O
noted	O	O
feature	O	O
being	O	O
the	O	O
posterior	O	O
lateral	O	O
aspect	O	O
of	O	O
the	O	O
left	O	O
chest	O	O
wall	O	O
with	O	O
rib	O	O
resection	O	O
and	O	O
soft	O	O
tissue	O	O
prominence	O	O
as	O	O
well	O	O
as	O	O
pleural	O	O
reactive	O	O
change	O	O
.	O	O
On	O	O
image	O	O
54	O	O
series	O	O
2	O	O
,	O	O
this	O	O
is	O	O
more	O	O
prominent	3_Yellow_Days	3_Yellow_Days
chest	3_Yellow_Days	3_Yellow_Days
wall	3_Yellow_Days	3_Yellow_Days
soft	3_Yellow_Days	3_Yellow_Days
tissues	3_Yellow_Days	3_Yellow_Days
in	O	3_Yellow_Days
the	O	3_Yellow_Days
subpleural	O	3_Yellow_Days
space	O	3_Yellow_Days
compared	O	O
to	O	O
01/07/2008	O	O
;	O	O
however	O	O
,	O	O
this	O	O
has	O	O
varied	O	O
and	O	O
was	O	O
prominent	O	O
on	O	O
the	O	O
prior	O	O
study	O	O
of	O	O
05/14/2007	O	O
as	O	O
well	O	O
,	O	O
and	O	O
suggest	3_Yellow_Days	O
clinical	3_Yellow_Days	O
correlation	3_Yellow_Days	O
to	O	O
see	O	O
if	O	O
there	O	O
are	O	O
any	O	O
signs	O	O
of	O	O
symptoms	O	3_Yellow_Days
of	O	3_Yellow_Days
disease	O	3_Yellow_Days
at	O	3_Yellow_Days
this	O	3_Yellow_Days
site	O	3_Yellow_Days
.	O	O
If	O	O
so	O	O
,	O	O
MRI	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
chest	3_Yellow_Days	O
wall	3_Yellow_Days	O
might	O	O
be	O	O
more	O	O
helpful	3_Yellow_Days	O
in	3_Yellow_Days	O
demonstrating	3_Yellow_Days	O
any	3_Yellow_Days	O
reactive	3_Yellow_Days	O
or	3_Yellow_Days	O
new	3_Yellow_Days	O
changes	3_Yellow_Days	O
.	O	O
However	O	O
,	O	O
at	O	O
this	O	O
time	O	O
,	O	O
these	O	O
features	O	O
are	O	O
fairly	O	O
consistent	O	O
with	O	O
posttreatment	O	O
changes	O	O
.	O	O
No	O	O
evidence	O	O
of	O	O
gross	O	O
or	O	O
new	O	O
disease	O	O
.	O	O
2	O	O
.	O	O
There	O	O
is	O	O
changes	O	O
in	O	O
the	O	O
left	O	O
shoulder	O	O
and	O	O
left	O	O
chest	O	O
wall	O	O
and	O	O
upper	O	O
arm	O	O
consistent	O	O
with	O	O
underlying	O	O
osteopenia	O	O
most	O	O
likely	O	O
related	O	O
to	O	O
the	O	O
prior	O	O
intervention	O	O
treatment	O	O
with	O	O
some	O	O
dysfunction	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MEDIASTINUM	O	O
PLEURA	O	O
300519019	O	O
49183	O	O
IMGCTT	O	O
CT	O	O
THORAX	O	O
CT	O	O
OF	O	O
THE	O	O
THORAX	O	O
:	O	O
4/27/07	O	O
.	O	O
COMPARISON	O	O
:	O	O
None	O	O
.	O	O
CLINICAL	O	O
HISTORY	O	O
:	O	O
Hemoptysis	O	O
.	O	O
TECHNIQUE	O	O
:	O	O
Multiple	O	O
contiguous	O	O
5	O	O
mm	O	O
axial	O	O
noncontrast	O	O
CT	O	O
images	O	O
of	O	O
the	O	O
thorax	O	O
.	O	O
Images	O	O
were	O	O
reconstructed	O	O
at	O	O
1.25	O	O
mm	O	O
slice	O	O
thickness	O	O
utilizing	O	O
a	O	O
sharp	O	O
kernel	O	O
.	O	O
FINDINGS	O	O
:	O	O
The	3_Yellow_Days	O
right	3_Yellow_Days	O
middle	3_Yellow_Days	O
lobe	3_Yellow_Days	O
bronchus	3_Yellow_Days	O
is	3_Yellow_Days	O
dilated	3_Yellow_Days	O
and	3_Yellow_Days	O
completely	3_Yellow_Days	O
obstructed	3_Yellow_Days	O
by	3_Yellow_Days	O
soft	3_Yellow_Days	O
tissue	3_Yellow_Days	O
.	O	O
There	O	O
are	O	O
also	O	O
secretions	3_Yellow_Days	O
filling	3_Yellow_Days	O
some	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
bronchi	3_Yellow_Days	O
.	O	O
Diffusely	3_Yellow_Days	O
throughout	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
lung	3_Yellow_Days	O
,	O	O
there	O	O
are	O	O
areas	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
centrilobular	3_Yellow_Days	3_Yellow_Days
ground-glass	3_Yellow_Days	3_Yellow_Days
opacities	3_Yellow_Days	3_Yellow_Days
,	3_Yellow_Days	O
some	3_Yellow_Days	O
with	3_Yellow_Days	O
a	3_Yellow_Days	O
tree-in	3_Yellow_Days	O
-	3_Yellow_Days	O
bud	3_Yellow_Days	O
configuration	3_Yellow_Days	O
,	O	O
as	O	O
well	O	O
as	O	O
``	O	O
crazy	O	O
paving	O	O
''	O	O
within	O	O
the	O	O
right	3_Yellow_Days	3_Yellow_Days
upper	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
.	O	O
To	3_Yellow_Days	O
a	3_Yellow_Days	O
lesser	3_Yellow_Days	O
extent	3_Yellow_Days	O
,	3_Yellow_Days	O
there	3_Yellow_Days	O
are	3_Yellow_Days	O
similar	3_Yellow_Days	O
findings	3_Yellow_Days	O
within	3_Yellow_Days	O
the	3_Yellow_Days	O
left	3_Yellow_Days	O
upper	3_Yellow_Days	O
lobe	3_Yellow_Days	O
and	3_Yellow_Days	O
lingula	3_Yellow_Days	O
.	O	O
Bronchiectasis	3_Yellow_Days	O
within	3_Yellow_Days	O
the	3_Yellow_Days	O
bilateral	3_Yellow_Days	O
lungs	3_Yellow_Days	O
,	O	O
right	O	O
greater	O	O
than	O	O
left	O	O
.	O	O
Shotty	O	3_Yellow_Days
mediastinal	O	3_Yellow_Days
lymph	O	3_Yellow_Days
nodes	O	3_Yellow_Days
,	O	3_Yellow_Days
subcentimeter	O	3_Yellow_Days
in	O	3_Yellow_Days
size	O	3_Yellow_Days
.	O	O
Incidentally	O	O
noted	O	O
is	O	O
a	O	O
3	O	O
mm	O	O
right	O	O
paratracheal	O	O
cyst	O	O
on	O	O
Series	O	O
3	O	O
,	O	O
Image	O	O
13	O	O
.	O	O
No	O	O
pericardial	O	O
effusion	O	O
.	O	O
Limited	O	O
examination	O	O
of	O	O
the	O	O
upper	O	O
abdomen	O	O
demonstrates	O	O
a	O	O
few	O	O
left	O	O
parapelvic	O	O
cysts	O	O
.	O	O
Regional	O	O
osseous	O	O
structures	O	O
demonstrate	O	O
no	O	O
suspicious	O	O
lesions	O	O
.	O	O
IMPRESSION	O	O
:	O	O
1	O	O
.	O	O
RIGHT	3_Yellow_Days	3_Yellow_Days
MIDDLE	3_Yellow_Days	3_Yellow_Days
LOBE	3_Yellow_Days	3_Yellow_Days
BRONCHOCELE	3_Yellow_Days	3_Yellow_Days
WITH	3_Yellow_Days	O
OBSTRUCTION	3_Yellow_Days	O
AND	3_Yellow_Days	O
FILLING	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
BRONCHUS	3_Yellow_Days	O
BY	3_Yellow_Days	O
EITHER	3_Yellow_Days	O
BLOOD	3_Yellow_Days	O
CLOT	3_Yellow_Days	O
OR	3_Yellow_Days	O
TUMOR	3_Yellow_Days	O
.	O	O
BRONCHIECTASIS	3_Yellow_Days	O
WITHIN	3_Yellow_Days	O
THE	3_Yellow_Days	O
BILATERAL	3_Yellow_Days	O
LUNGS	3_Yellow_Days	O
,	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
GREATER	3_Yellow_Days	O
THAN	3_Yellow_Days	O
LEFT	3_Yellow_Days	O
.	O	O
CENTRILOBULAR	3_Yellow_Days	O
GROUND-GLASS	3_Yellow_Days	O
NODULES	3_Yellow_Days	O
,	3_Yellow_Days	O
PREDOMINANTLY	3_Yellow_Days	O
THROUGHOUT	3_Yellow_Days	O
THE	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
LUNG	3_Yellow_Days	O
WITH	O	O
AREAS	O	O
OF	O	O
``	O	O
CRAZY	3_Yellow_Days	O
PAVING	3_Yellow_Days	O
''	O	O
.	O	O
CONSTELLATION	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
FINDINGS	3_Yellow_Days	3_Yellow_Days
CAN	3_Yellow_Days	3_Yellow_Days
BE	3_Yellow_Days	3_Yellow_Days
SEEN	3_Yellow_Days	O
WITH	3_Yellow_Days	O
BLOOD	3_Yellow_Days	O
CLOT	3_Yellow_Days	O
WITHIN	3_Yellow_Days	O
THE	3_Yellow_Days	O
BRONCHI	3_Yellow_Days	O
AND	3_Yellow_Days	O
ASPIRATION	3_Yellow_Days	O
INTO	3_Yellow_Days	O
THE	3_Yellow_Days	O
LUNGS	3_Yellow_Days	O
.	O	O
ALTERNATIVELY	O	O
,	O	O
AN	3_Yellow_Days	O
UNDERLYING	3_Yellow_Days	O
NEOPLASM	3_Yellow_Days	O
IS	3_Yellow_Days	O
NOT	3_Yellow_Days	O
EXCLUDED	3_Yellow_Days	O
.	O	O
RECOMMEND	3_Yellow_Days	O
BRONCHOSCOPY	3_Yellow_Days	O
TO	3_Yellow_Days	O
FURTHER	3_Yellow_Days	O
EVALUATE	3_Yellow_Days	O
.	O	O
2	O	O
.	O	O
PRELIMINARY	3_Yellow_Days	O
FINDINGS	3_Yellow_Days	O
DISCUSSED	3_Yellow_Days	O
WITH	O	O
DR.	O	O
FELDMAN	O	O
BY	O	O
THE	O	O
RADIOLOGY	O	O
ON	O	O
CALL	O	O
RESIDENT	O	O
ON	O	O
4/27/07	O	O
.	O	O
FINAL	O	O
READING	O	O
ALSO	O	O
DISCUSSED	O	O
WITH	O	O
DR.	O	O
WALTER	O	O
CHENG	O	O
ON	O	O
4/27/07	O	O
.	O	O
END	O	O
OF	O	O
IMPRESSION	O	O
:	O	O
SUMMARY	O	O
:4	O	O
-	O	O
POSSIBLE	O	O
SIGNIFICANT	O	O
FINDINGS	O	O
,	O	O
MAY	O	O
NEED	O	O
ACTION	O	O
I	O	O
have	O	O
personally	O	O
reviewed	O	O
the	O	O
images	O	O
for	O	O
this	O	O
examination	O	O
and	O	O
agree	O	O
with	O	O
the	O	O
report	O	O
transcribed	O	O
above	O	O
.	O	O
By	O	O
:	O	O
Ann	O	O
N.	O	O
Leung	O	O
,	O	O
M.D.	O	O
on	O	O
:	O	O
04/28/2007	O	O
09:42	O	O
011.90	O	O
117.3	O	O
174.8	O	O
174.9	O	O
211.3	O	O
244.9	O	O
272.4	O	O
277.00	O	O
285.9	O	O
401.1	O	O
39001565	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
Chest	O	O
CT	O	O
,	O	O
08/04/2009	O	O
Clinical	O	O
History	O	O
:	O	O
Colon	O	O
cancer	O	O
.	O	O
Technique	O	O
:	O	O
A	O	O
2.5	O	O
mm	O	O
spiral	O	O
CT	O	O
was	O	O
performed	O	O
from	O	O
the	O	O
lung	O	O
apices	O	O
to	O	O
the	O	O
bases	O	O
utilizing	O	O
intravenous	O	O
contrast	O	O
.	O	O
Findings	O	O
:	O	O
No	O	O
lung	O	O
nodules	O	O
suspicious	O	O
for	O	O
metastatic	O	O
disease	O	O
is	O	O
definitely	O	O
seen	O	O
.	O	O
Dependent	O	O
atelectasis	O	O
is	O	O
noted	O	O
.	O	O
There	O	O
is	O	O
scarring	O	O
in	O	O
the	O	O
lung	O	O
apices	O	O
.	O	O
There	O	O
appears	O	O
to	O	O
be	O	O
granulomatous	O	3_Yellow_Days
disease	O	3_Yellow_Days
.	O	O
The	O	O
kyphosis	O	O
is	O	O
noted	O	O
.	O	O
There	O	O
appear	O	O
to	O	O
be	O	O
stable	O	O
compression	3_Yellow_Days	O
fractures	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
spine	3_Yellow_Days	O
and	3_Yellow_Days	O
there	3_Yellow_Days	O
appears	3_Yellow_Days	O
to	3_Yellow_Days	O
be	3_Yellow_Days	O
osteopenia	3_Yellow_Days	O
.	O	O
The	O	O
esophagus	3_Yellow_Days	O
is	O	O
again	O	O
noted	O	O
to	O	O
be	O	O
patulous	O	O
and	O	O
has	O	O
an	O	O
air	3_Yellow_Days	3_Yellow_Days
fluid	3_Yellow_Days	3_Yellow_Days
level	3_Yellow_Days	3_Yellow_Days
within	3_Yellow_Days	3_Yellow_Days
it	3_Yellow_Days	3_Yellow_Days
.	O	O
Clinical	3_Yellow_Days	O
correlation	3_Yellow_Days	O
for	3_Yellow_Days	O
dysphagia	3_Yellow_Days	O
is	3_Yellow_Days	O
suggested	3_Yellow_Days	O
.	O	O
No	O	O
esophageal	O	O
mass	O	O
is	O	O
definitely	O	O
seen	O	O
.	O	O
Low	3_Yellow_Days	3_Yellow_Days
attenuation	3_Yellow_Days	3_Yellow_Days
lesions	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	O
the	3_Yellow_Days	O
thyroid	3_Yellow_Days	O
gland	3_Yellow_Days	O
are	3_Yellow_Days	O
again	3_Yellow_Days	O
noted	3_Yellow_Days	O
and	3_Yellow_Days	O
again	3_Yellow_Days	O
suggest	3_Yellow_Days	O
goiter	3_Yellow_Days	O
;	3_Yellow_Days	O
clinical	3_Yellow_Days	O
correlation	3_Yellow_Days	O
suggested	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
mild	O	O
degenerative	O	O
changes	O	O
of	O	O
both	O	O
shoulders	O	O
and	O	O
moderate	O	O
degenerative	O	O
change	O	O
of	O	O
the	O	O
spine	O	O
.	O	O
Old	O	O
left	O	O
rib	O	O
fractures	O	O
are	O	O
again	O	O
appreciated	O	O
.	O	O
Please	O	O
see	O	O
the	O	O
abdomen	O	O
CT	O	O
report	O	O
of	O	O
the	O	O
same	O	O
day	O	O
for	O	O
findings	O	O
in	O	O
the	O	O
abdomen	O	O
.	O	O
IMPRESSION	O	O
:	O	O
No	O	O
definite	O	O
evidence	O	O
of	O	O
metastatic	O	O
disease	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
MCW	O	O
1816650	O	O
SOB	O	O
CT	O	O
THORAX	O	O
AND	O	O
CT	O	O
PELVIS	O	O
-	O	O
PE	O	O
PROTOCOL	O	O
-LRB-	O	O
#	O	O
836A-B	O	O
-RRB-	O	O
TECHNIQUE	O	O
:	O	O
HELICAL	O	O
CT	O	O
THROUGH	O	O
THE	O	O
THORAX	O	O
AFTER	O	O
ADMINISTRATION	O	O
OF	O	O
CONTRAST	O	O
IS	O	O
PERFORMED	O	O
AND	O	O
REVIEWED	O	O
AS	O	O
CONTIGUOUS	O	O
1.25	O	O
MM	O	O
SLICES	O	O
.	O	O
DELAYED	O	O
LIMITED	O	O
VIEWS	O	O
THROUGH	O	O
THE	O	O
LOWER	O	O
PELVIS	O	O
AND	O	O
LOWER	O	O
EXTREMITIES	O	O
WERE	O	O
ALSO	O	O
PERFORMED	O	O
.	O	O
CORONAL	O	O
AND	O	O
SAGITTAL	O	O
REFORMATS	O	O
ARE	O	O
ALSO	O	O
PROVIDED	O	O
.	O	O
FINDINGS	O	O
:	O	O
NO	O	O
CERVICAL	O	O
OR	O	O
AXILLARY	O	O
LYMPHADENOPATHY	O	O
IS	O	O
SEEN	O	O
.	O	O
THE	O	O
GREAT	O	O
VESSELS	O	O
APPEAR	O	O
NORMAL	O	O
.	O	O
MEDIASTINAL	O	O
LYMPH	O	O
NODES	O	O
ARE	O	O
PROMINENT	O	O
,	O	O
AND	O	O
THERE	O	O
IS	O	O
MILD	3_Yellow_Days	O
STRANDING	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
MEDIASTINUM	3_Yellow_Days	O
.	O	O
THE	O	O
CARDIAC	3_Yellow_Days	O
SIZE	3_Yellow_Days	O
IS	3_Yellow_Days	O
LARGE	3_Yellow_Days	O
.	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
INTERLOBULAR	3_Yellow_Days	3_Yellow_Days
SEPTAL	3_Yellow_Days	3_Yellow_Days
THICKENING	3_Yellow_Days	3_Yellow_Days
IS	O	O
APPRECIATED	O	O
.	O	O
THERE	O	O
IS	O	O
BRONCHIAL	3_Yellow_Days	O
CUFFING	3_Yellow_Days	O
.	O	O
THERE	O	O
IS	O	O
MILD	3_Yellow_Days	3_Yellow_Days
DIFFUSE	3_Yellow_Days	3_Yellow_Days
GROUND-GLASS	3_Yellow_Days	3_Yellow_Days
OPACITY	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
PULMONARY	3_Yellow_Days	O
VESSELS	3_Yellow_Days	O
ARE	3_Yellow_Days	O
CONGESTED	3_Yellow_Days	O
.	O	O
NO	O	O
PULMONARY	O	O
EMBOLISM	O	O
IS	O	O
IDENTIFIED	O	O
.	O	O
BILATERAL	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
EFFUSIONS	3_Yellow_Days	3_Yellow_Days
ARE	O	O
SEEN	O	O
.	O	O
LIMITED	O	O
VIEWS	O	O
THROUGH	O	O
THE	O	O
UPPER	O	O
ABDOMEN	O	O
REVEAL	O	O
SIGNIFICANT	O	O
CONTRAST	O	O
REFLUX	O	O
INTO	O	O
THE	O	O
HEPATIC	O	O
VENOUS	O	O
SYSTEM	O	O
.	O	O
A	O	O
CALCIFIED	O	O
GRANULOMA	O	O
IS	O	O
SEEN	O	O
IN	O	O
THE	O	O
SPLEEN	O	O
.	O	O
NO	O	O
DEEP	O	O
VENOUS	O	O
THROMBOSIS	O	O
IS	O	O
SEEN	O	O
.	O	O
NO	O	O
SIGNIFICANT	O	O
BONY	O	O
ABNORMALITIES	O	O
ARE	O	O
DETECTED	O	O
.	O	O
1	O	O
.	O	O
NO	O	O
PULMONARY	O	O
EMBOLISM	O	O
OR	O	O
DEEP	O	O
VENOUS	O	O
THROMBOSIS	O	O
IDENTIFIED	O	O
.	O	O
2	O	O
.	O	O
CARDIOMEGALY	3_Yellow_Days	3_Yellow_Days
AND	O	3_Yellow_Days
INTERSTITIAL	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
EDEMA	3_Yellow_Days	3_Yellow_Days
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O
71250	O	O
CT	O	O
CHEST	O	O
wo	O	O
CT	O	O
05/05/2007	O	O
Contrast	O	O
enhanced	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
with	O	O
comparison	O	O
to	O	O
recent	O	O
PE	O	O
study	O	O
of	O	O
4/30/07	O	O
.	O	O
Exam	O	O
is	O	O
read	O	O
in	O	O
conjunction	O	O
with	O	O
the	O	O
Indium-111	O	O
labeled	O	O
white	O	O
blood	O	O
cell	O	O
study	O	O
of	O	O
5/4/07	O	O
.	O	O
Degenerative	O	O
arthritis	O	O
with	O	O
vacuum	O	O
phenonomen	O	O
in	O	O
the	O	O
mid	O	O
thoracic	O	O
spine	O	O
.	O	O
Thoracic	O	O
kyphosis	O	O
.	O	O
Compression	3_Yellow_Days	O
fractures	3_Yellow_Days	O
of	3_Yellow_Days	O
T4-T7	3_Yellow_Days	O
vertebral	3_Yellow_Days	O
bodies	3_Yellow_Days	O
.	O	O
Also	O	O
mild	3_Yellow_Days	3_Yellow_Days
compression	3_Yellow_Days	3_Yellow_Days
L1	3_Yellow_Days	3_Yellow_Days
.	O	O
No	O	O
evidence	O	O
of	O	O
posterior	O	O
mediastinal	O	O
mass	O	O
or	O	O
abscess	O	O
.	O	O
MRI	O	O
would	O	O
be	O	O
more	O	O
sensitive	O	O
in	O	O
further	O	O
evaluation	O	O
for	O	O
discitis/osteomyelitis	O	O
.	O	O
Slight	3_Yellow_Days	3_Yellow_Days
interval	3_Yellow_Days	3_Yellow_Days
increase	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
bilateral	3_Yellow_Days	3_Yellow_Days
pleural	3_Yellow_Days	3_Yellow_Days
effusions	3_Yellow_Days	3_Yellow_Days
since	O	O
the	O	O
PE	O	O
study	O	O
of	O	O
4/30/07	O	O
.	O	O
Associated	O	O
compressive	O	O
atelectasis/infiltrates	O	O
.	O	O
New	3_Yellow_Days	O
,	3_Yellow_Days	O
hazy	3_Yellow_Days	O
infiltrate	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
upper	3_Yellow_Days	O
lung	3_Yellow_Days	O
anteriorly	3_Yellow_Days	O
.	O	O
Otherwise	O	O
no	O	O
significant	O	O
change	O	O
from	O	O
previous	O	O
.	O	O
Small	3_Yellow_Days	3_Yellow_Days
pericardial	3_Yellow_Days	3_Yellow_Days
effusion	3_Yellow_Days	3_Yellow_Days
or	3_Yellow_Days	3_Yellow_Days
thickening	3_Yellow_Days	O
.	O	O
Aortic	O	O
calcification	O	O
.	O	O
Cholelithiasis	O	O
.	O	O
Cortical	O	O
scarring	O	O
both	O	O
kidneys	O	O
.	O	O
Watchman	O	O
device	O	O
in	O	O
the	O	O
left	O	O
atrial	O	O
appendage	O	O
with	O	O
thrombus	O	O
.	O	O
Fatty	O	O
atrophy	O	O
of	O	O
the	O	O
pancreas	O	O
.	O	O
05/07/2007	O	O
ES	O	O
>	O	O
<	O	O
REPOCT	O	O
of	O	O
the	O	O
chest	O	O
without	O	O
contrast	O	O
media	O	O
as	O	O
per	O	O
coronary	O	O
calcification	O	O
protocol	O	O
.	O	O
CT	O	O
scan	O	O
of	O	O
the	O	O
heart	O	O
was	O	O
done	O	O
to	O	O
evaluate	O	O
for	O	O
coronary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
calcification	3_Yellow_Days	3_Yellow_Days
.	O	O
The	O	O
examination	O	O
is	O	O
positive	O	O
and	O	O
shows	O	O
definite	O	O
calcium	3_Yellow_Days	O
deposits	3_Yellow_Days	O
which	O	O
are	O	O
diagnostic	O	O
of	O	O
atherosclerotic	O	O
disease	O	O
.	O	O
The	O	O
calcium	3_Yellow_Days	O
score	3_Yellow_Days	O
is	3_Yellow_Days	O
5	3_Yellow_Days	O
.	O	O
This	O	O
score	O	O
places	O	O
this	O	O
patient	O	O
in	O	O
the	O	O
42	O	O
percentile	O	O
for	O	O
quantity	O	O
of	O	O
calcification	O	O
for	O	O
her	O	3_Yellow_Days
age	O	O
and	O	O
gender	O	O
group	O	O
when	O	O
compared	O	O
to	O	O
our	O	O
age	O	O
and	O	O
gender	O	O
matched	O	O
control	O	O
group	O	O
.	O	O
There	O	O
is	O	O
calcification	O	3_Yellow_Days
at	O	O
the	O	O
proximal	3_Yellow_Days	O
left	3_Yellow_Days	O
anterior	3_Yellow_Days	O
descending	3_Yellow_Days	O
coronary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
.	O	O
Remainder	O	O
is	O	O
negative	O	O
.	O	O
39313949	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
Thorax	O	O
with	O	O
intravenous	O	O
contrast	O	O
,	O	O
10/25/2009	O	O
Clinical	O	O
History	O	O
:	O	O
High-grade	O	O
serous	O	O
carcinoma	O	O
of	O	O
the	O	O
ovary	O	O
,	O	O
evaluate	O	O
disease	O	O
status	O	O
.	O	O
Comparison	O	O
:	O	O
08/11/2009	O	O
.	O	O
Findings	O	O
:	O	O
A	O	O
subcentimeter	3_Yellow_Days	O
pulmonary	3_Yellow_Days	O
nodule	3_Yellow_Days	O
in	O	O
the	O	O
left	3_Yellow_Days	3_Yellow_Days
upper	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
,	O	O
in	O	O
the	O	O
right	3_Yellow_Days	O
middle	3_Yellow_Days	O
lobe	3_Yellow_Days	O
near	O	O
the	O	O
horizontal	O	O
fissure	O	O
and	O	O
in	O	O
the	O	O
right	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
-LRB-	O	O
series	O	O
4	O	O
,	O	O
image	O	O
33	O	O
,	O	O
52	O	O
and	O	O
79	O	O
-RRB-	O	O
remain	3_Yellow_Days	3_Yellow_Days
unchanged	3_Yellow_Days	3_Yellow_Days
since	O	O
06/25/2008	O	O
.	O	O
They	O	O
are	O	O
indeterminate	3_Yellow_Days	O
and	O	O
can	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
followed	3_Yellow_Days	3_Yellow_Days
for	3_Yellow_Days	3_Yellow_Days
a	3_Yellow_Days	3_Yellow_Days
total	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
2	3_Yellow_Days	O
years	3_Yellow_Days	O
to	3_Yellow_Days	O
determine	3_Yellow_Days	O
stability	3_Yellow_Days	O
.	O	O
Elsewhere	O	O
,	O	O
nodular	O	O
thickening	O	O
along	O	O
the	O	O
major	O	O
fissures	O	O
remain	O	O
unchanged	O	O
.	O	O
Minimal	O	3_Yellow_Days
dependent	O	3_Yellow_Days
pleural	O	3_Yellow_Days
thickening	O	3_Yellow_Days
in	O	O
the	O	O
left	O	3_Yellow_Days
lower	O	3_Yellow_Days
lobe	O	3_Yellow_Days
is	O	3_Yellow_Days
overall	O	3_Yellow_Days
unchanged	O	3_Yellow_Days
.	O	O
There	O	O
is	O	O
otherwise	O	O
,	O	O
no	O	O
pleural	O	O
effusions	O	O
.	O	O
No	O	O
abnormally	O	O
enlarged	O	O
lymph	O	O
nodes	O	O
lie	O	O
within	O	O
the	O	O
thorax	O	O
.	O	O
Osseous	O	O
metastasis	O	O
is	O	O
absent	O	O
.	O	O
The	O	O
tip	O	O
of	O	O
a	O	O
right	O	O
port	O	O
catheter	O	O
lies	O	O
in	O	O
the	O	O
SVC	O	O
.	O	O
IMPRESSION	O	O
:	O	O
A	3_Yellow_Days	O
few	3_Yellow_Days	3_Yellow_Days
indeterminate	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
remain	3_Yellow_Days	3_Yellow_Days
stable	3_Yellow_Days	3_Yellow_Days
and	O	3_Yellow_Days
can	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
followed	3_Yellow_Days	3_Yellow_Days
for	3_Yellow_Days	3_Yellow_Days
a	3_Yellow_Days	3_Yellow_Days
total	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
2	3_Yellow_Days	O
years	3_Yellow_Days	O
to	3_Yellow_Days	O
determine	3_Yellow_Days	O
stability	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
otherwise	O	O
,	O	O
no	O	O
obvious	O	O
metastatic	O	O
disease	O	O
to	O	O
the	O	O
thorax	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O

